#NERX - Twitter Hashtag

almost 3 years ago · Boston

Grateful of presenting our new generation of Ku-DBi’s and their unique mechanism of action of DNA-PK inhibition at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston. B068 #Targets23 #IUSOM #turchilab #NERx #cancer #DDR

Pame_Mendoza's tweet photo. Grateful of presenting our new generation of Ku-DBi’s and their unique mechanism of action of DNA-PK inhibition at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston. B068 #Targets23 #IUSOM #turchilab #NERx #cancer #DDR https://t.co/ZZ48nxfEgV

0

7

2

0

468

Pame Mendoza @Pame_Mendoza

over 3 years ago · Iowa City

We had a really good time presenting our work on Ku-DNA binding inhibitors at the 22nd Midwest DNA repair symposium in Iowa city #turchilab #cancerresearch #IUSOM #NERx

Pame_Mendoza's tweet photo. We had a really good time presenting our work on Ku-DNA binding inhibitors at the 22nd Midwest DNA repair symposium in Iowa city #turchilab #cancerresearch #IUSOM #NERx https://t.co/lOiIRR3XQy

0

9

0

323

Pame Mendoza @Pame_Mendoza

over 3 years ago

I am pleased to announce our most recent work on Ku-DNA binding inhibition and combination with DNA-DSB inducing agents to modulate the DDR via ATM and p53-dependent cell death. https://t.co/AmdCLND8AV #turchilab #NERx @johnturchi @NAR_Cancer_EIC

0

13

4

0

406

North End Runners @northendrunners

over 3 years ago

Great big year about to go off 🔥🔥🔥 #tenNER #NERX #tenyears #crewloveforever #stillcrushing #nevernotrunning https://t.co/RCRqzIrOhD

northendrunners's tweet photo. Great big year about to go off 🔥🔥🔥 #tenNER #NERX #tenyears #crewloveforever #stillcrushing #nevernotrunning https://t.co/RCRqzIrOhD https://t.co/BJNKWRJlR7

0

2

0

174

Pame Mendoza @Pame_Mendoza

almost 4 years ago

We are presenting today our two pre-clinical pipeline drugs targeting the DNA Damage Response pathway, that may have a broad impact on curing two of the most common and deadly cancers: lung and breast. #ENASymp22 #IUSM #turchilab #NERx

Pame_Mendoza's tweet photo. We are presenting today our two pre-clinical pipeline drugs targeting the DNA Damage Response pathway, that may have a broad impact on curing two of the most common and deadly cancers: lung and breast. #ENASymp22 #IUSM #turchilab #NERx https://t.co/MhhnsfKAx6

2

10

0

Pame Mendoza @Pame_Mendoza

almost 4 years ago

Excited on presenting our two pre-clinical pipeline drugs targeting the DNA Damage Response pathway, that may have a broad impact on curing lung and breast cancer. ENA Molecular Targets and Cancer Therapeutics Conference, Barcelona, Spain 2022 #ENASymp22 #IUSM #turchilab #NERx

0

5

0